The 37 rating InvestorsObserver gives to Stealth BioTherapeutics Corp (MITO) stock puts it near the bottom of the Biotechnology industry. In addition to scoring higher than 28 percent of stocks in the Biotechnology industry, MITOs 37 overall rating means the stock scores better than 37 percent of all stocks.
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 37 means the stock is more attractive than 37 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.
Stealth BioTherapeutics Corp (MITO) stock is trading at $1.42 as of 10:38 AM on Friday, Jan 8, a rise of $0.04, or 2.9% from the previous closing price of $1.38. The stock has traded between $1.39 and $1.45 so far today. Volume today is light. So far 122,117 shares have traded compared to average volume of 815,884 shares.
Click Here to get the full Stock Score Report on Stealth BioTherapeutics Corp (MITO) Stock.
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
You May Also Like
More here:
Is Stealth BioTherapeutics Corp (MITO) a Winner in the Biotechnology Industry? - InvestorsObserver
Recommendation and review posted by G. Smith
